| 000 | 09479nam a22010937a 4500 | ||
|---|---|---|---|
| 008 | 140202b ck ||||| |||| 00| 0 spa d | ||
| 020 | _a9780781774772 -- 978-0-7817-7477-2 -- 0-7817-7477-2 | ||
| 082 | 0 | 4 | _a616.86 / P957p |
| 245 | 1 | 0 | _aPrinciples of addiction medicine / senior editor Richard K. Ries, Shannon C. Miller ; associate editors |
| 245 | 1 | 0 | _aDavid A. Fiellin, Richard Saitz |
| 250 | _a4ª ed. | ||
| 264 | _aPhiladelphia : Lippincott Williams & Wilkins, 2009 | ||
| 300 | _axxix, 1570 p. : tres colores ; 28 x 21.5 cm. | ||
| 505 | 0 | 0 | _aBasic science and core concepts -- Dreug Addiction: The Neurobiology of Behavior Gone Awry -- The |
| 505 | 0 | 0 | _aepidemiology of Substance Use Disorders -- The Anatomy of Addiction -- From Neurobiology to Treatment: |
| 505 | 0 | 0 | _aProgress Against Addiction -- Understanding Behavioral Addiction: Insights from Research -- Pharmacology -- |
| 505 | 0 | 0 | _aPharmacokinetic and Pharmacodynamic Principles -- The Pharmacology of Alcohol -- The Pharmacology of |
| 505 | 0 | 0 | _aNanalcohol Sedative Hypnotics -- FHB -- The Pharmacology of Long-Acting as Contrasted with Shor-Acting Opiods |
| 505 | 0 | 0 | _a-- The pharmacology of Coacine, Amphetamines, and Other Stimulants -- The Pharmacology of Caffeine -- The |
| 505 | 0 | 0 | _aPharmacology of Nicotine and Tobacco -- The Pharmacology of Cannabinoids -- The Pharmacology of Classical |
| 505 | 0 | 0 | _aHallucinogens and Related Designer Drugs -- The Pharmacology of Dissociatives -- The Pharmacology of Inhalants |
| 505 | 0 | 0 | _a-- The Pharmacology of Anabolic Androgenis Streroids -- Diagnosis, Assessment and Early Intervention -- |
| 505 | 0 | 0 | _aScreening and Brief Intervention -- Screening and Bref Intervention for Pregnant Women -- Trauma Centers, |
| 505 | 0 | 0 | _aHosapitals, Emergency Departaments -- Implementation of Screening and Brief Intervention in Clinical Settings |
| 505 | 0 | 0 | _aUsing Quality Improvement Pinciples -- Screning for Alcoholism and Other Drug Abuse in the Elderly -- |
| 505 | 0 | 0 | _aLaboratory Diagnosis -- Assessment -- Environmental Approaches to Prevention -- Overview of Addiction |
| 505 | 0 | 0 | _aTreatment -- Addiction Medicine in America: Its Birth and Early History (1750-1935) with A Modern Postscript |
| 505 | 0 | 0 | _a-- Treatment of Heavy Drinking and Alcohol Use Disorders -- The Treatment of Drug Addiction: And Overview -- |
| 505 | 0 | 0 | _aIntegrating Evidence-Bassed Components into a Functional Continuum of Addiction Care -- Effects of Treatment |
| 505 | 0 | 0 | _aSetting, Duration, and Amount on Patiente Outcomes -- The ASAM Placement Criteria and Matching Patients to |
| 505 | 0 | 0 | _aTreatment -- Linking Addiction Treatment with Other Medical and Psychiatric Treatment Systems -- Alternative |
| 505 | 0 | 0 | _aTherapies for Alcohol and Drug Addiction -- The Harm Reduction Approach to Preention and Treatment -- Quality |
| 505 | 0 | 0 | _aImprovement for Addiction Treatment -- International Perspective on Addiction Management -- Special Issues in |
| 505 | 0 | 0 | _aAddicion Medicine -- Nonmedical Use of Prescription Medications -- Special Issues in Treatment: Women -- |
| 505 | 0 | 0 | _aTreatment of Older Adults -- Cultural Issues in Adicction -- College Student Drinking -- Pathologic Gambring: |
| 505 | 0 | 0 | _aClinical Charactertistics and Treatment -- Sexual Adicction -- Physician Health Programs adn Addiction Among |
| 505 | 0 | 0 | _aPhysicians -- Management of Intoxication and Withdrawal -- Management of Alcohol Intoxication and Withdrwal -- |
| 505 | 0 | 0 | _aManagement of Sedative-Hypnotic Intoxication and Withdrawal -- Management of Opioid Intoxication and |
| 505 | 0 | 0 | _aWithdrawal -- Ultrarapid Opiate Detoxification -- Management of Stimulant, Hallucinogen, Marijuana, |
| 505 | 0 | 0 | _aPhencyclidine, and Club Drug Intoxication and Withdrawal -- Pharmacology Interventions -- Medications for Use |
| 505 | 0 | 0 | _ain Alcohol Rehabilitation -- Pharmacologic Interventions for Sedative-Hypnotic Addiction -- Pharmacologic |
| 505 | 0 | 0 | _aInterventions for Opioid Dependence -- Opioid Maintenance Treatment -- Special Issues in Office-Based Opioid |
| 505 | 0 | 0 | _aTreatment -- Pharmacologic Interventions for Cocaine, Methamphetamine, and Other Stimulant Addiction -- |
| 505 | 0 | 0 | _aPharmacology Intervention for Tobacco Dependence -- Pharmacology Intervention for Other Drug and Multiple Drug |
| 505 | 0 | 0 | _aAddictions -- Behavioral Interventions -- Enhancing Motivation to Change -- Grup Therapies -- Individual |
| 505 | 0 | 0 | _aPsychotherapy -- Contingency Management and the Community Reinforcement Approach -- Behavioral Interventions |
| 505 | 0 | 0 | _ain Smoking Cessation -- Network Therapy -- Therapeutic Communities -- Overview of Therapeutic Community |
| 505 | 0 | 0 | _aOutcome Research -- Aversion Therapies -- Family Involvement in Addiction, Treatment and Recovery -- Twelve |
| 505 | 0 | 0 | _aStrep Facilitation Approaches -- Microprocessor Abuse and Internet Addiction -- Relapse Prevention: Clinical |
| 505 | 0 | 0 | _aModels and Intervention Strategies -- Integrating Pharmacological and Behavioral Treatments -- Mutual Help, |
| 505 | 0 | 0 | _aTwelve Strep, and Other Recovery Programs -- Recent Research into Twelve Strep Programs -- Spirituality in the |
| 505 | 0 | 0 | _aRevoery Process -- Medical Disorders and Complications of Addiction -- Medical and Surgical Complications of |
| 505 | 0 | 0 | _aAddiction -- Cardiovascular Consequences of Alcohol and Other drug -- Liver Disorders Related no Alcohol and |
| 505 | 0 | 0 | _aOther Drug Use -- Renal and Metabolic Disorders Related to alcohol and Other Drug Use -- Gastrointestinal |
| 505 | 0 | 0 | _aDisorders Related to Alcohol and Other Drug Use -- Respiratory Tract Disorders Related to alcohol and Other |
| 505 | 0 | 0 | _aDrug Use -- Neurologic Disordern Related to Alcohol and Other Drug Use -- HIV, TB, and Other Infectious |
| 505 | 0 | 0 | _aDiseases Related to Alcohol and Other Drug Use -- Sleep Disorders Related to Alcohol and Other Drug Use -- |
| 505 | 0 | 0 | _aTraumatic Injuries Related to Alcohol and Other Drug Use -- Endocrine and Reproductive Disorders Related to |
| 505 | 0 | 0 | _aAlcohol and Other drug use -- Alcohol and Other Drug Use Drugin Pregnancy: Management of the Mother and Child |
| 505 | 0 | 0 | _a-- Surgical interventions in The alcohol or drug using patient -- Co-occuring Addiction and psychiatric |
| 505 | 0 | 0 | _aDisorders -- Substancde-Unduced Mental Disorders -- Co-occurring Addiction and Affective Disorders -- |
| 505 | 0 | 0 | _aCo-occuring Addiction and Anxiety Disorders -- Co-ocurring Addiction and Psychotic Disorders -- Co-occuring |
| 505 | 0 | 0 | _aAddiction and Attention Deficit/Hyperativity Disorder -- Co-occuring Addiction and Borderline Personality |
| 505 | 0 | 0 | _aDisorder -- Integrating Psychosocial Services with Pharmacotherapies in the Treatment of Co-occurring |
| 505 | 0 | 0 | _aDisorders -- Posttraumatic Stress Disorder and Substance Use Disorder Comorbidity -- Co-occuring Addiction and |
| 505 | 0 | 0 | _aEeating Disorders -- Pain and Addiction -- The Neurophysiology of Pain and Interfaces With Addiction -- |
| 505 | 0 | 0 | _aPsychological Issues in the Management of Pain -- Monopioid treatments in the Management of Pain -- Opioid |
| 505 | 0 | 0 | _aThrapy of Pain -- Leal and Regulatory Considerations in Pain Management -- Children and Adolescents -- |
| 505 | 0 | 0 | _aAdolescents' attitudes Toward Alcohol and Other Drugs -- Preventing Substance Abue among Children and |
| 505 | 0 | 0 | _aAdolescents -- Adoelscent Risk and Protective Factors: Psychosocial -- Neurobiology of Addiction from a |
| 505 | 0 | 0 | _aDevelopment Perspective -- Adolescent Cigarrette Smoking -- Screening and Brief Intervention for Adolescents |
| 505 | 0 | 0 | _a-- Assessing Adolescents Substance use -- Adolescent Treatment and Realpse Prevention -- Placement Criteria |
| 505 | 0 | 0 | _aand Strategies for Adoelscent Treatment Marching -- Confidentiality in Dealing with Adoelscents -- Drug |
| 505 | 0 | 0 | _aTesting Adolescents in School -- Co-occuring Psychiatric Disorders in Adolescents -- Ethical, Legal, and |
| 505 | 0 | 0 | _aLiability Issues in Addiction Practice -- Ethical Issues in Addiction Practice -- Consent and Confidentiality |
| 505 | 0 | 0 | _ain Addiction Practice -- Clinical and legal consideations in Prescribing Drugs with Abuse Potential -- |
| 505 | 0 | 0 | _aClinical and Legal Considerations in Drug Testing -- Workplace Drug Testing and the Role of the Medical Review |
| 505 | 0 | 0 | _aOfficer -- Drug Court and the Treatment of Incarcerated Populations -- Therapeutic Jurisprudence -- Appendices |
| 505 | 0 | 0 | _a-- ASAM Addiction Terminology -- Screening Instruments -- Crosswalks of the ASAM Patient Placement Criteria, |
| 505 | 0 | 0 | _aSecond Editiom Revisedd, (ASAM PPC-2R) -- Summary of the DSM Diagnostic Criteria -- Summary of the ICD-10 |
| 505 | 0 | 0 | _aDiagnostic Criteria -- Federal Schedules of Controlled Drugs -- Index -- |
| 650 | 1 | 4 |
_aAbuso de substancias _xtratamiento _999107 |
| 650 | 1 | 4 |
_aDesordenes relacionados a sustancias _xcomplicaciones _9106611 |
| 650 | 1 | 4 |
_aDesordenes relacionados a sustancia _xdiagnosis _9106610 |
| 650 | 1 | 4 |
_aDesordenes relacionados a sustancias _xterapia _9106611 |
| 650 | 1 | 4 |
_aDrogas _xefectos fisiológicos _9107329 |
| 650 | 1 | 4 |
_aMedicina _9115965 |
| 650 | 1 | 4 |
_aSalud _9130891 |
| 700 | 1 |
_aRies, Richard K _eed. _978334 |
|
| 700 | 1 |
_aMiller, Shannon C. _eed. _967390 |
|
| 700 | 1 |
_aFiellin, David A. _eed. _942852 |
|
| 700 | 1 |
_aSaitz, Richard _eed. _981382 |
|
| 710 | 1 |
_aASAM - American Society of Addiction Medicine _992182 |
|
| 999 |
_c26748 _d26748 |
||